ovalbumin and Dyslipidemias

ovalbumin has been researched along with Dyslipidemias* in 1 studies

Other Studies

1 other study(ies) available for ovalbumin and Dyslipidemias

Article	Year
Exposure to PM Lipids in health and disease, 2019, Aug-07, Volume: 18, Issue:1 Epidemiological studies have confirmed atmospheric PM. Rats were treat with ovalbumin (OVA) to establish asthma models. Notch signaling pathway inhibitor (DAPT) was injected intraperitoneally. Asthmatic and healthy rats were exposed to different concentrations of PM. Hes1 expression levels in healthy and asthma pathway inhibition groups were lower than those in control groups. Compared with control group, rats exposed to PM. PM Topics: Animals; Asthma; Cholesterol, HDL; Cholesterol, LDL; Diamines; Disease Models, Animal; Dyslipidemias; Female; Gene Expression; Lipid Metabolism; Male; Ovalbumin; Particulate Matter; Rats; Rats, Wistar; Signal Transduction; Thiazoles; Transcription Factor HES-1; Triglycerides	2019

Article

Year

Lipids in health and disease, 2019, Aug-07, Volume: 18, Issue:1

Epidemiological studies have confirmed atmospheric PM. Rats were treat with ovalbumin (OVA) to establish asthma models. Notch signaling pathway inhibitor (DAPT) was injected intraperitoneally. Asthmatic and healthy rats were exposed to different concentrations of PM. Hes1 expression levels in healthy and asthma pathway inhibition groups were lower than those in control groups. Compared with control group, rats exposed to PM. PM

Topics: Animals; Asthma; Cholesterol, HDL; Cholesterol, LDL; Diamines; Disease Models, Animal; Dyslipidemias; Female; Gene Expression; Lipid Metabolism; Male; Ovalbumin; Particulate Matter; Rats; Rats, Wistar; Signal Transduction; Thiazoles; Transcription Factor HES-1; Triglycerides

2019